For the year ending 2025-12-31, ACNT had $41,498K increase in cash & cash equivalents over the period. -$2,063K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Operating Segments-Specialty Chemicals Segment | 17,212 |
| Corporate Non Segment | 0 |
| Gross profit | 17,212 |
| Operating Segments-Specialty Chemicals Segment | 0 |
| Corporate Non Segment | 71 |
| Research and development | 71 |
| Selling, general and administrative expense | 22,961 |
| Depreciation & amortization | 1,132 |
| Acquisition costs and other | 731 |
| Operating Segments-Specialty Chemicals Segment | 0 |
| Corporate Non Segment | 1,622 |
| Asset impairments | 1,622 |
| Operating Segments-Specialty Chemicals Segment | 0 |
| Corporate Non Segment | 2,278 |
| Gain on lease modification | 2,278 |
| Interest (income) expense, net | 712 |
| Income taxes | 22 |
| Other (income) expense, net | 753 |
| Net loss from continuing operations | -5,584 |
| Depreciation expense | 3,574 |
| Amortization expense | 612 |
| Amortization of debt issuance costs | 258 |
| Asset impairments | 1,622 |
| Deferred income taxes | 22 |
| (reduction of) provision for losses on accounts receivable | -569 |
| Loss on disposal of property, plant and equipment | -1 |
| Non-cash lease expense | 128 |
| Gain on lease modification | 2,278 |
| Share-based compensation expense | 1,302 |
| Accounts receivable and advances | 2,576 |
| Inventories | 3,015 |
| Other assets and liabilities | 521 |
| Accounts payable | -1,565 |
| Accrued expenses | 1,469 |
| Accrued income taxes | -149 |
| Net cash (used in) provided by operating activities - continuing operations | -7,269 |
| Net cash provided by operating activities - discontinued operations | 6,750 |
| Net cash (used in) provided by operating activities | -519 |
| Purchases of property, plant and equipment | 1,544 |
| Net cash used in investing activities - continuing operations | -1,544 |
| Net cash provided by investing activities - discontinued operations | 52,525 |
| Net cash provided by investing activities | 50,981 |
| Borrowings from credit facilities | 137,075 |
| Proceeds from note payable | 1,085 |
| Proceeds from exercise of stock options | 415 |
| Payments on credit facilities | 137,075 |
| Payments on note payable | 1,021 |
| Principal payments on finance lease obligations | 287 |
| Repurchase of common stock | 9,137 |
| Net cash used in financing activities - continuing operations | -8,945 |
| Net cash used in financing activities - discontinued operations | -19 |
| Net cash used in financing activities | -8,964 |
| Increase in cash and cash equivalents | 41,498 |
| Cash and cash equivalents of discontinued operations | 0 |
| Cash and cash equivalents, beginning of period | 16,108 |
| Cash and cash equivalents, end of period | 57,606 |
ASCENT INDUSTRIES CO. (ACNT)
ASCENT INDUSTRIES CO. (ACNT)